Clare Gerrard, Author at Neuroendocrine Cancer UK

Multidisciplinary management of neuroendocrine neoplasms during the COVID-19 pandemic

by Clare Gerrard | Jan 4, 2021

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era Neuroendocrine neoplasms (NENs) are a heterogeneous family of uncommon tumours with challenging diagnosis,...

NCUK 2020 Grant Winner

by Clare Gerrard | Dec 21, 2020

We are delighted to award the 2020 NCUK grant to Dr Marc Ooft, Consultant Histopathologist, Kings College Hospital. His research alongside the NET GeCIP group is focusing on ‘Improving patient stratification through epigenetic and tumour microenvironment...

No deal Brexit could have detrimental impact for four million people in UK living with a rare disease

by Clare Gerrard | Dec 16, 2020

No deal Brexit could have detrimental impact for four million people in UK living with a rare disease Experts have warned that a ‘no deal’ Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the...

NCUK update re Covid19 vaccine(s)

by Clare Gerrard | Dec 7, 2020

NCUK update re Covid19 vaccine(s) Please note : as with all aspects of care for those with Neuroendocrine Cancer, NCUK recommends discussion with your specialist team to ensure you have all of the information you need, tailored to your specific circumstances, to...

The Galleri blood test

by Clare Gerrard | Dec 7, 2020

An innovative blood test that may spot more than 50 types of cancer will be piloted by the NHS in a world-leading programme, announced by NHS chief executive Sir Simon Stevens on November 27th. The Galleri blood test, developed by GRAIL, has the potential to detect...

Multidisciplinary management of neuroendocrine neoplasms during the COVID-19 pandemic

NCUK 2020 Grant Winner

No deal Brexit could have detrimental impact for four million people in UK living with a rare disease

NCUK update re Covid19 vaccine(s)

The Galleri blood test

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us